Medical Research Council (MRC), AstraZeneca, University of Cambridge · GB · UKRI
This scheme funds collaborations with the functional genomics screening laboratory (FGSL) on projects using complex human in vitro models for CRISPR screening to better understand model biology and enable target identification. The service from the FGSL is already funded, but cost will be considered when assessing project feasibility. Applicants must be researchers eligible for MRC funding, and UK-based industry parties may also be considered.
Applicants must be researchers eligible for MRC funding. Applications from UK-based industry parties may also be considered. See UKRI opportunity page for eligibility and institutional requirements.
Not stated
Where each item on this page was read from, so every claim can be verified against the original. “Official ↗” opens the funder page the value came from; anything we could not reach or parse is listed under Not captured / obstacles below.
| Curated item | Value in this record | Source |
|---|---|---|
| Funding agency | Medical Research Council (MRC), AstraZeneca, University of Cambridge | Official page ↗ |
| Country / funding source | GB · UKRI | Official page ↗ |
| Deadline | Not stated | Official page ↗ |
| Funding amount | Not stated on the official page | Official page ↗ |
| Eligibility | 3 structured dimensions — see the eligibility panel above | Official page ↗ |
Data is collected from official funder pages only. Figures are machine-curated (rule + LLM where noted) and should be re-verified on the linked source before use.